1. robertweimer
2. joaniesee
3. robwhitelock
4. studiobeing
1.joaniesee 01/24/2018
ChemoCentryx Announces Positive Overall Survival Results with CCR2 Inhibitor CCX872 for Locally Advanced/Metastatic Pancreatic Cancer
2.joaniesee 01/03/2018
News to come. - ChemoCentryx to Present at the 36th Annual J.P. Morgan Healthcare Conference
3.robertweimer 05/17/2018
Canaccord Genuity initiates as a buy, $17PT
4.robertweimer 01/24/2018
Small boost today
5.robwhitelock 09/13/2018
Granted FDA orphan drug designation for the treatment of focal segmental glomerulosclerosis
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW